Stocks›Healthcare›MEDP

MEDP

Medpace Holdings, Inc.
NasdaqResearch view
$618.88−0.28%
Sep 25 close · 1D EOD · Databento
HealthcareServices-Commercial Physical & Biological ResearchLarge-capSEC EDGAR FY 2025-12-31

The numbers · FY2025, filed

SEC EDGAR
Market cap$17.3B
Revenue$2.5B+20.00%
Net income$451.1M
EPS, diluted$15.28+21.00%
Operating margin21.1%
Return on equity98.3%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$17.3B
Enterprise Value$16.8B
Income$451.1M
Sales$2.5B
Book/sh$16.45
Cash/sh$17.81
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio—
Current Ratio0.74
Debt/Eq—
EPS (ttm)$15.28
EPS this Y21.0%
EPS past 3/5Y28.0%
Sales past 3/5Y20.1%
EPS Y/Y TTM21.0%
Sales Y/Y TTM20.0%
Shs Outstand27.91M
ROA22.8%
ROE98.3%
ROIC—
Gross Margin—
Oper. Margin21.1%
Profit Margin17.8%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$1.1B
FY21
$1.5B
FY22
$1.9B
FY23
$2.1B
FY24
$2.5B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%21%18%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.